1 天
Zacks.com on MSN3 Top Cancer Biotechs to Keep An Eye On in 2025If the cancer space appeals to you, it's time to consider stocks like Novartis, Exact Sciences and Monte Rosa.
Sight-robbing injuries to the cornea can be repaired using a groundbreaking experimental stem cell treatment, a new study ...
Retinoblastoma is a rare eye cancer that develops as a tumour — abnormal growth of cells — in the retina, the layer of ...
3 天on MSNOpinion
The Trump administration is impeding the National Institutes of Health-backed science that enabled treatment of ...
The Trump administration is impeding the National Institutes of Health-backed science that enabled treatment of ...
Nicola, an early years teacher, from Manchester, said: “I started experiencing tingling in my left cheek. At first, I thought ...
This game-changing pill is a simple aspirin. A study has found that this pill may have the ability to destroy tumour cells by ...
Hundreds of people in England with a rare form of cancer affecting the eye will soon be able to access a pioneering therapy based on T-cell receptor (TCR) technology, developed by Immunocore.
Mar. 3, 2025 — Researchers have developed an innovative tool that enhances surgeons' ability to detect and remove cancer cells during cryosurgery, a procedure that uses extreme cold to destroy ...
Results from a phase 1/2 clinical trial of a novel stem cell treatment for cornea injuries found 14 patients treated and tracked for 18 months had a more than 90% success rate at restoring the ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果